Post Transplant High-Dose Cy as GvHD Prophylaxis in 1 HLA Mismatched Unrelated HSCT for Myeloid Malignancies
Clinical trial NCT03270748 · COMPLETED
Trial details
- NCT number
- NCT03270748
- Sponsor
- Gruppo Italiano Trapianto di Midollo Osseo
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-15
- Primary completion
- 2022-11-20
- Enrollment
- 78
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.